stella
beta
Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia — Stella
Recruiting
Back to Autoimmune Thrombocytopenia trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Peking Union Medical College Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov